^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    GuardantREVEAL

    Company:
    Guardant Health
    Type:
    Laboratory Developed Test
    Related tests:

    Details

    Evidence
    News
    GuardantREVEAL is a tissue-free liquid biopsy test for MRD detection and recurrence monitoring. It uses a blood sample to analyze thousands of epigenomic (methylation) signals combined with genomic alterations to quantify tumor fraction in ctDNA. Available for early-stage colorectal, breast, and lung cancers.
    Cancer:
    Breast Cancer, Colorectal Cancer, Lung Cancer
    Method:
    Next-Generation Sequencing (NGS)